Long-axial-field of View in Prostate Cancer Next Generation Imaging: the Launch Pad of Theragnostic

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2024 Feb 14

PMID 38351388

Authors

Fabio Volpe

Carmela Nappi

Michele Klain

Affiliations

Soon will be listed here.

References

Luining W, Cysouw M, Meijer D, Hendrikse N, Boellaard R, Vis A . Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer. Cancers (Basel). 2022; 14(5). PMC: 8909566. DOI: 10.3390/cancers14051169. View

Luining W, Hagens M, Meijer D, Ringia J, de Weijer T, Bektas H . The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer. Eur Urol Open Sci. 2024; 59:55-62. PMC: 10829602. DOI: 10.1016/j.euros.2023.12.001. View

Delgado Bolton R, Calapaqui Teran A, Almeida L, Taieb D, Giammarile F . Bridging the Gap Between Clinical Suspicion of Neuroendocrine Tumors and Diagnosis With PET/CT When Pathology Is Unavailable: Considerations on Guidelines and Real Access to State-of-the-Art Molecular Imaging. Clin Nucl Med. 2024; 49(3):226-227. DOI: 10.1097/RLU.0000000000005003. View

Zhi Y, Higuchi T, Hackenberg S, Hagen R, Stoth M, Scherzad A . [F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients. Endocrine. 2023; 84(2):656-662. PMC: 11076315. DOI: 10.1007/s12020-023-03645-8. View

Gu B, Liu X, Wang S, Xu X, Liu X, Hu S . Head-to-head evaluation of [F]FDG and [ Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma. Eur J Nucl Med Mol Imaging. 2022; 49(8):2889-2901. PMC: 9206606. DOI: 10.1007/s00259-022-05700-4. View

Mankoff D, Balogova S, Dunnwald L, Dehdashti F, DeVries E, Evangelista L . Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[F]Fluoro-17β-Estradiol PET. J Nucl Med. 2023; 65(2):221-223. DOI: 10.2967/jnumed.123.266938. View

Nappi C, Zampella E, Gaudieri V, Volpe F, Piscopo L, Vallone C . Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via F-Sodium Fluoride PET/CT Imaging. J Clin Med. 2024; 13(2). PMC: 10816004. DOI: 10.3390/jcm13020569. View

Guglielmo P, Alongi P, Baratto L, Abenavoli E, Buschiazzo A, Celesti G . Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature. Life (Basel). 2023; 13(9). PMC: 10533171. DOI: 10.3390/life13091821. View

Klain M, Maurea S, Gaudieri V, Zampella E, Volpe F, Manganelli M . The diagnostic role of total-body F-FDG PET/CT in patients with multiple tumors: a report of the association of thyroid cancer with lung or renal tumors. Quant Imaging Med Surg. 2021; 11(9):4211-4215. PMC: 8339643. DOI: 10.21037/qims-21-36. View

10.

Romeo V, Maurea S, Guarino S, Mainenti P, Liuzzi R, Petretta M . The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results. Abdom Radiol (NY). 2017; 43(8):2119-2129. DOI: 10.1007/s00261-017-1429-4. View

11.

Piscopo L, Nappi C, Volpe F, Romeo V, Nicolai E, Gallicchio R . Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer. Cancers (Basel). 2022; 14(12). PMC: 9220891. DOI: 10.3390/cancers14122958. View

12.

Yan J, Schaefferkoette J, Conti M, Townsend D . A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise. Cancer Imaging. 2016; 16(1):26. PMC: 5002150. DOI: 10.1186/s40644-016-0086-0. View

13.

Chang T, Chang G, Clark J, Diab R, Rohren E, Mawlawi O . Reliability of predicting image signal-to-noise ratio using noise equivalent count rate in PET imaging. Med Phys. 2012; 39(10):5891-900. PMC: 3808417. DOI: 10.1118/1.4750053. View

14.

Salvadori J, Odille F, Verger A, Olivier P, Karcher G, Marie P . Head-to-head comparison between digital and analog PET of human and phantom images when optimized for maximizing the signal-to-noise ratio from small lesions. EJNMMI Phys. 2020; 7(1):11. PMC: 7035408. DOI: 10.1186/s40658-020-0281-8. View

15.

Akamatsu G, Uba K, Taniguchi T, Mitsumoto K, Narisue A, Tsutsui Y . Impact of Time-of-Flight PET/CT with a Large Axial Field of View for Reducing Whole-Body Acquisition Time. J Nucl Med Technol. 2014; 42(2):101-4. DOI: 10.2967/jnmt.114.140665. View

16.

Triumbari E, Rufini V, Mingels C, Rominger A, Alavi A, Fanfani F . Long Axial Field-of-View PET/CT Could Answer Unmet Needs in Gynecological Cancers. Cancers (Basel). 2023; 15(9). PMC: 10177015. DOI: 10.3390/cancers15092407. View

17.

Vandenberghe S, Moskal P, Karp J . State of the art in total body PET. EJNMMI Phys. 2020; 7(1):35. PMC: 7248164. DOI: 10.1186/s40658-020-00290-2. View

18.

Daube-Witherspoon M, Cherry S . Scanner Design Considerations for Long Axial Field-of-View PET Systems. PET Clin. 2020; 16(1):25-39. PMC: 7680401. DOI: 10.1016/j.cpet.2020.09.003. View

19.

Alberts I, Sari H, Mingels C, Afshar-Oromieh A, Pyka T, Shi K . Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients. Cancer Imaging. 2023; 23(1):28. PMC: 10024603. DOI: 10.1186/s40644-023-00540-3. View

20.

Slart R, Tsoumpas C, Glaudemans A, Noordzij W, Willemsen A, Borra R . Long axial field of view PET scanners: a road map to implementation and new possibilities. Eur J Nucl Med Mol Imaging. 2021; 48(13):4236-4245. PMC: 8566640. DOI: 10.1007/s00259-021-05461-6. View